Your browser doesn't support javascript.
loading
Early assessment of minimal residual disease in AML by flow cytometry during aplasia identifies patients at increased risk of relapse.
Köhnke, T; Sauter, D; Ringel, K; Hoster, E; Laubender, R P; Hubmann, M; Bohlander, S K; Kakadia, P M; Schneider, S; Dufour, A; Sauerland, M-C; Berdel, W E; Büchner, T; Wörmann, B; Braess, J; Hiddemann, W; Spiekermann, K; Subklewe, M.
Afiliação
  • Köhnke T; Department of Internal Medicine III, University of Munich, Munich, Germany.
  • Sauter D; Department of Internal Medicine III, University of Munich, Munich, Germany.
  • Ringel K; Department of Internal Medicine III, University of Munich, Munich, Germany.
  • Hoster E; 1] Department of Internal Medicine III, University of Munich, Munich, Germany [2] Institute of Medical Informatics, Biometry and Epidemiology (IBE), University of Munich, Munich, Germany.
  • Laubender RP; Institute of Medical Informatics, Biometry and Epidemiology (IBE), University of Munich, Munich, Germany.
  • Hubmann M; Department of Internal Medicine III, University of Munich, Munich, Germany.
  • Bohlander SK; 1] Department of Internal Medicine III, University of Munich, Munich, Germany [2] Department of Human Genetics, Philipps University Marburg, Marburg, Germany.
  • Kakadia PM; Department of Human Genetics, Philipps University Marburg, Marburg, Germany.
  • Schneider S; Department of Internal Medicine III, University of Munich, Munich, Germany.
  • Dufour A; Department of Internal Medicine III, University of Munich, Munich, Germany.
  • Sauerland MC; Institute of Biostatistics and Clinical Research, University of Münster, Münster, Germany.
  • Berdel WE; Department of Internal Medicine IIIA, University of Münster, Münster, Germany.
  • Büchner T; Department of Internal Medicine IIIA, University of Münster, Münster, Germany.
  • Wörmann B; German Society of Hematology and Oncology (DGHO), Berlin, Germany.
  • Braess J; Department of Hematology and Oncology, Barmherzige Brüder Hospital, Regensburg, Germany.
  • Hiddemann W; 1] Department of Internal Medicine III, University of Munich, Munich, Germany [2] Clinical Cooperation Group Acute Myeloid Leukemia, Helmholtz Zentrum Munich, German Research Center for Environmental Health, Munich, Germany.
  • Spiekermann K; 1] Department of Internal Medicine III, University of Munich, Munich, Germany [2] Clinical Cooperation Group Acute Myeloid Leukemia, Helmholtz Zentrum Munich, German Research Center for Environmental Health, Munich, Germany [3] German Cancer Consortium (DKTK), Heidelberg, Germany [4] German Cancer R
  • Subklewe M; 1] Department of Internal Medicine III, University of Munich, Munich, Germany [2] Clinical Cooperation Group Immunotherapy, Helmholtz Zentrum Munich, German Research Center for Environmental Health, Munich, Germany.
Leukemia ; 29(2): 377-86, 2015 Feb.
Article em En | MEDLINE | ID: mdl-24912430
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Medula Óssea / Células da Medula Óssea / Leucócitos Mononucleares / Leucemia Mieloide Aguda / Neoplasia Residual / Recidiva Local de Neoplasia Tipo de estudo: Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Medula Óssea / Células da Medula Óssea / Leucócitos Mononucleares / Leucemia Mieloide Aguda / Neoplasia Residual / Recidiva Local de Neoplasia Tipo de estudo: Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article